We would like to inform everyone about The Learning Conference 2015 organized by the environment for university teaching at UiB.
As part of the programme there will be a separate session on the University’s upcoming learning platform, Canvas, and the opportunities inherent in this for educators at UiB. Participation is free.
Please register here.
Best regards
Ørjan Leren
Faculty of Medicine and Dentistry
University of Bergen
Tel: +47 55 58 64 85
To those of you who have not yet registered all of your holiday for 2015 in Pagaweb: Please make sure that you register your remaining holiday this year. Deadline: October 31st, 2015.
If you have not registered and / or applied for transference of your holiday by the 31th of October we will consider your holiday as spent and register this in PAGA.
Transfer of vacation:
As a rule all vacation should be completed before the end of the year. You can still apply to have as many as 14 vacation days transferred to the next year via PAGA. In the application you must explain your plan for these days in 2016 / or why
you have not been able to take all the vacation in 2015 (only sic leave and leave of absence will be consideed as valid reasons). Continue reading
A core facility is a collection of scientific equipment and highly qualified technical staff made widely available to the research community. The three current core facilities at the Department of Clinical Science: Flow Cytometry Core Facility, Genomics Core Facility and Metabolomics Core Facility, cover important common functions by MOF and UiB as well as regionally and nationally. They are available to all academic users on the same favorable terms and for commercial users of the University’s conditions for contract research.
The department administers the Faculty’s policy regarding sharing of costs and co-authorship when faculty core facilities are used. This policy means that all higher education researchers in Norway, health trusts included, gain access on equal terms, including the same price. More on this see: http://www.uib.no/mofa/67221/kostnadsdeling-og-medforfatterskap (in Norwegian).
The economy of all core facilities will be partially secured through user fees, and through operating models which address the need for reinvestment and equipment renewal.
To ensure that the core facilities are able to provide the best possible service to the communities it is a goal that they are tightly integrated with scientists who are leaders in their fields. Use of core facilities should thus be a more attractive option than buying your own equipment and pay own technical staff, both cost-wise and methodical. Experience has shown that core facilities are the best way to give researchers in Norway access to an updated and maintained instrument park, and to the methodological knowledge they do not have themselves and equipment and staff they could not afford.
The way the core facilities at MOF are operated is based on experiences from the NRC FUGE initiative. The core facilities are operated and financed by the Department / MOF in cooperation with the University of Bergen, Helse Bergen, Helse Vest, the Faculty of Science, Bergen Research Foundation, NRC, and individual groups of researchers.
Important to remember – If the use of a core facility forms part of the basis for a scientific publication the core facility should be mentioned in the acknowledgment section of the publication, for example: “Parts of the work was carried out at the NAME OF CORE FACILITY and was thus supported by the Faculty of Medicine and Dentistry at the University of Bergen and its partners “.
Two great new additions to be especially mentioned are: CyTOF – Mass cytometry with single-cell proteomic opportunities – for Flow (equipment has been delivered and is being tested), and NRC infrastructure funds for equipment for complete human genome sequencing to Genomics.
Roland
The value of the small things in health and medical technology
The Research Council of Norway, Lysaker October 27th 2015 Continue reading
Oslo, June 23-25 2016. See attachment for more information.
October 2nd 2015 Bergens Tidende reported that logging devices have been found on PCs at the Norwegian School of Economics (NHH). In connection with this, we would like to inform about this kind of surveillance and which measures we can take as an organization.
See information on http://www.uib.no/en/it/92126/illegal-logging-devices-pc-mac-and-linux
Regards,
The IT Department
You can now read an article about new courses and reports in project management, and also one about the follow-up of the research program.
We would like to inform you about this year’s announcement of Vita Hjertego “1 kr til Hjertesaken” which is the allocation of funds to research and other activities in preventive heart health. Continue reading
Thursday October 15th at 08:30 CET at Christie Café (University Aula).
Near learning is central.
About exams and alternative assessment forms. Continue reading
in IT, CY, CZ, PL, S, DE, LT, GR.
Upcoming events: don’t miss the chance to join our courses! Continue reading
Refreshments will be served before the lecture (which starts at 4:15 pm). Everybody is welcome!
Read more about the lecture. Facebook event.
Join the Horizons group on Facebook.
Attached you will find an invitation (in Norwegian) to a half-day seminar on the new curriculum in medicine Wednesday November 4th at 8:30 am to 12:00 pm. Place: Large auditorium, 3rd floor, Sentralblokken, Haukeland.
We meet for joint discussions and teaching input in dealing with the new curriculum. The main part of the seminar contains presentations of sketches by semester chairmen for 3. – 6. semester. The sketches will be sent to departments and other semester boards before the seminar, so the seminar will be the venue for discussions ahead of the program selection processing November 11th. Registration before 26 October.
Regards,
Kristin Walter
Project Secretary New Curriculum Medicine
Medicine and Dentistry
University in Bergen
Tel. 55 58 65 59
Based on last week’s search for “Department of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to elin.opheim@uib.no.
Menopause as a predictor of new-onset asthma: A longitudinal Northern European population study.
Triebner K, Johannessen A, Puggini L, Benediktsdóttir B, Bertelsen RJ, Bifulco E, Dharmage SC, Dratva J, Franklin KA, Gíslason T, Holm M, Jarvis D, Leynaert B, Lindberg E, Malinovschi A, Macsali F, Norbäck D, Omenaas ER, Rodríguez FJ, Saure E, Schlünssen V, Sigsgaard T, Skorge TD, Wieslander G, Zemp E, Svanes C, Hustad S, Gómez Real F.
J Allergy Clin Immunol. 2015 Oct 1. pii: S0091-6749(15)01243-9.
High incidence of heterozygous ABCC8 and HNF1A mutations in Czech patients with congenital hyperinsulinism.
Rozenkova K, Malikova J, Nessa A, Dusatkova L, Bjørkhaug L, Obermannova B, Dusatkova P, Kytnarova J, Aukrust I, Najmi L, Rypackova B, Sumnik Z, Lebl J, Njølstad PR, Hussain K, Pruhova S.
J Clin Endocrinol Metab. 2015 Oct 2:jc20152763.
Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer.
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Bandera EV, Bean Y, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix-Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Plisiecka-Halasa J, Dennis J, Dicks E, Doherty JA, Dörk T, du Bois A, Eccles D, Easton DT, Edwards RP, Eilber U, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goode EL, Goodman MT, Gronwald J, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall E, Hogdall C, Hosono S, Jakubowska A, Paul J, Jensen A, Karlan BY, Kjaer SK, Kelemen LE, Kellar M, Kelley JL, Kiemeney LA, Krakstad C, Lambrechts D, Lambrechts S, Le ND, Lee AW, Cannioto R, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Noor Azmi MA, Odunsi K, Olson SH, Orlow I, Orsulic S, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Phelan CM, Pike MC, Poole EM, Ramus SJ, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Budzilowska A, Sellers TA, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Sucheston L, Tangen IL, Teo SH, Terry KL, Thompson PJ, Timorek A, Tworoger SS, Van Nieuwenhuysen E, Vergote I, Vierkant RA, Wang-Gohrke S, Walsh C, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Coetzee GA, Freedman ML, Monteiro AN, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PD, Gayther SA, Schildkraut JM.
Carcinogenesis. 2015 Sep 29. pii: bgv138.
Nutrition in allogeneic stem cell transplantation – Clinical guidelines and immunobiological aspects.
Tvedt TH, Reikvam H, Bruserud Ø.
Curr Pharm Biotechnol. 2015 Sep 30.
Glycogenin-2 is dispensable for liver glycogen synthesis and glucagon-stimulated glucose release.
Irgens HU, Fjeld K, Johansson BB, Ringdal M, Immervoll H, Leh S, Søvik O, Johansson S, Molven A, Njølstad PR.
J Clin Endocrinol Metab. 2015 May;100(5):E767-75.
The tuberculin skin test in school going adolescents in South India: associations of socio-demographic and clinical characteristics with TST positivity and non-response.
Uppada DR, Selvam S, Jesuraj N, Bennett S, Verver S, Grewal HM, Vaz M; TB Trials Study Group.
BMC Infect Dis. 2014 Nov 18;14:571.